Titre :

Transcatheter heart valve interventions: where are we? where are we going?

Auteur(s) :

Prendergast, Bernard D. [Auteur]
Baumgartner, Helmut [Auteur]
Delgado, Victoria [Auteur]
Gerard, Olivier [Auteur]
Haude, Michael [Auteur]
Himmelmann, Anders [Auteur]
Iung, Bernard [Auteur]
Leafstedt, Matthew [Auteur]
Lennartz, Jasmine [Auteur]
Maisano, Francesco [Auteur]
Marinelli, Elena Andreassi [Auteur]
Modine, Thomas [Auteur]
Troubles cognitifs dégénératifs et vasculaires - U 1171 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U 1171 [TCDV]
Mueller, Markus [Auteur]
Redwood, Simon R. [Auteur]
Rorick, Olaf [Auteur]
Sahyoun, Cherif [Auteur]
Saillant, Erika [Auteur]
Sondergaard, Lars [Auteur]
Thoenes, Martin [Auteur]
Thomitzek, Karen [Auteur]
Tschernich, Marion [Auteur]
Vahanian, Alec [Auteur]
Wendler, Olaf [Auteur]
Zemke, Evelyn Julia [Auteur]
Bax, Jeroen J. [Auteur]

Titre de la revue :

European heart journal

Nom court de la revue :

Eur. Heart J.

Date de publication :

2019-01-04

ISSN :

1522-9645

Mot(s)-clé(s) en anglais :

Tricuspid valve
Heart valve disease
Transcatheter aortic valve replacement
Aortic valve
Mitral valve

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

Transcatheter heart valve interventions have transformed the outcomes of patients with valvular heart disease (VHD) who are unfavourable candidates for surgery. Technological advances have allowed extension of these ...
Lire la suite >Transcatheter heart valve interventions have transformed the outcomes of patients with valvular heart disease (VHD) who are unfavourable candidates for surgery. Technological advances have allowed extension of these interventions to younger or lower risk patients and those with other forms of VHD and may in the future permit earlier treatment of VHD in less symptomatic patients or those with moderate disease. The balance of risks and benefits is likely to differ between lower and higher risk patients, and more evidence is needed to evaluate the net benefit of transcatheter technology in these groups. As academic researchers, clinicians, industry, and patient stakeholders collaborate to research these broader indications for transcatheter valve interventions, it is essential to address (i) device durability and deliverability, (ii) specific anatomical needs (e.g. bicuspid aortic valves, aortic regurgitation, mitral and tricuspid valve disease), (iii) operator training, and (iv) the reinforced importance of the multidisciplinary Heart Team.Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

CHU Lille
CNRS
Inserm
Université de Lille

Collections :

• Autres travaux scientifiques

Date de dépôt :

2019-11-27T14:30:55Z